The Artificial Pancreas Does Its Homework

JDRF-funded researchers across the globe are currently testing artificial pancreas systems. Some clinical trials are inpatient, in which participants stay overnight or for a few days in a hospital or research clinic, while others take place in an outpatient setting. In both cases, a medical team carefully monitors the daily life of each trial volunteer […]

A Father’s Formula

“How is managing diabetes like navigating an airplane?” That may sound like the beginning of a bad joke, but the answer resulted in a promising innovation in T1D treatment in JDRF’s current research portfolio. Like many other parents of children with type 1 diabetes (T1D), Don Matheson is well versed in the latest research advances […]

Progress in Testing Artificial Pancreas Systems in Clinical and Real-World Settings

A first-of-its-kind clinical pilot study has demonstrated the safety and feasibility of an artificial pancreas system in an outpatient, “real-world” setting. A second clinical study has shown that a hypoglycemia-hyperglycemia minimizer system can predict when blood-glucose levels are about to rise or fall and make appropriate adjustments in insulin delivery. These JDRF-supported studies represent critical steps on the path to a functional artificial pancreas for the benefit of people living with T1D.

JDRF Launches Online Clinical Service

Over its nearly 40-year history, JDRF has funded more than $1.3 billion toward a cure, accelerating science to the point where we are now funding more than 40 human clinical trials. For people with type 1 diabetes, getting information about trials, and making a decision to enroll in one, is difficult, time-consuming, and often confusing. Plus, funded scientists are finding it harder and harder to enroll participants in trials in a timely and cost-efficient way. Clinical Trials Connection helps make it easier for people with type 1 diabetes to take part in clinical trials, while addressing the difficulty researchers are having in finding trial participants.

JDRF Trial Shows Continuous Glucose Monitoring Improves Blood Sugar Control

Continuous glucose monitors are more than simply devices of convenience for people with diabetes—they are tools that can substantially improve blood sugar control when used regularly. The CGM study also underscores the importance of continued research into a closed-loop artificial pancreas, a device that uses CGM data to automatically administer appropriate doses of insulin through a pump.